Канал: VascularNews

Scientific and societal backing for multimodality topical oxygen therapy herald “new era”

Scientific and societal backing for multimodality topical oxygen therapy herald “new era”

CX co-chairs host discussion on studies looking at pre-emptive AAA sac management

CX co-chairs host discussion on studies looking at pre-emptive AAA sac management

Luminor anticipated to have “big impact” on Japanese market following SOL-Japan results

Luminor anticipated to have “big impact” on Japanese market following SOL-Japan results

Long-term IN.PACT AV data show there is “definitely a place” for DCBs in dialysis access

Long-term IN.PACT AV data show there is “definitely a place” for DCBs in dialysis access

IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB therapy

IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB therapy

FORS-powered LumiGuide has “gold-standard” potential for 3D device guidance without radiation

FORS-powered LumiGuide has “gold-standard” potential for 3D device guidance without radiation

Get a glimpse at how endovascular procedures could be conducted in the future…

Get a glimpse at how endovascular procedures could be conducted in the future…

Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace standard of care”

Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace standard of care”

iCover’s radiopaque markers and full encapsulation help it stand out from competitors

iCover’s radiopaque markers and full encapsulation help it stand out from competitors

Laurent Chiche│3D device guidance without radiation is the future

Laurent Chiche│3D device guidance without radiation is the future

Is the cardiovascular centre the future?

Is the cardiovascular centre the future?

“Go for it, you are qualified,” new and future leaders advised at VSASM 2023

“Go for it, you are qualified,” new and future leaders advised at VSASM 2023

First-time presentation: IN.PACT AV Access five-year data lays paclitaxel mortality concerns to rest

First-time presentation: IN.PACT AV Access five-year data lays paclitaxel mortality concerns to rest

Who, why and where: Experts address key questions on the future of aortic arch treatment

Who, why and where: Experts address key questions on the future of aortic arch treatment

Isabelle Van Herzeele│3D device guidance without radiation is the future

Isabelle Van Herzeele│3D device guidance without radiation is the future

Using "wall-to-wall" mechanical thrombectomy in DVT treatment

Using "wall-to-wall" mechanical thrombectomy in DVT treatment

Bijan Modarai│3D device guidance without radiation is the future

Bijan Modarai│3D device guidance without radiation is the future

“There are a lot of possibilities”: Deep learning in the vascular space

“There are a lot of possibilities”: Deep learning in the vascular space

Mechanical thrombectomy “safe and effective” for treatment of acute limb ischaemia

Mechanical thrombectomy “safe and effective” for treatment of acute limb ischaemia

European study aims to provide “snapshot” of current ALI treatment strategies

European study aims to provide “snapshot” of current ALI treatment strategies

Daniel Clair - Vascular News profile

ESVS president discusses advocates patient-centric care and endovascular therapies

ESVS president discusses advocates patient-centric care and endovascular therapies

“We still have a lot more work to do”: Professor reflects on representation of women in specialty

“We still have a lot more work to do”: Professor reflects on representation of women in specialty

DRS combination of scaffold and antirestenotic drug will “really advance” treatment options

DRS combination of scaffold and antirestenotic drug will “really advance” treatment options

Active sac management represents “step forward” for EVAR

Active sac management represents “step forward” for EVAR

Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?

Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?

Deep vein arterialisation: “A real advance” for treatment of ‘no-option’ CLTI

Deep vein arterialisation: “A real advance” for treatment of ‘no-option’ CLTI

“First victory” in BTK space demonstrates lessons learned and paves the way for real-world analysis

“First victory” in BTK space demonstrates lessons learned and paves the way for real-world analysis

Optimal management of vascular wounds: Patient-specific decisions and multidisciplinary care are key

Optimal management of vascular wounds: Patient-specific decisions and multidisciplinary care are key

Expanding the treatment window for the effective management of DVT

Expanding the treatment window for the effective management of DVT

Nectero EAST System a potential “game changer” for smaller infrarenal abdominal aortic aneurysms

Nectero EAST System a potential “game changer” for smaller infrarenal abdominal aortic aneurysms

Shape memory polymer: “Another step down the road” toward active aneurysm sac management

Shape memory polymer: “Another step down the road” toward active aneurysm sac management

Pilot study seeks to highlight BEST endovascular strategy for complex lesions

Pilot study seeks to highlight BEST endovascular strategy for complex lesions

Long-awaited US FDA update on paclitaxel-coated devices - Andrew Holden

Long-awaited US FDA update on paclitaxel-coated devices - Andrew Holden

Data in the pipeline for “toolbox” of saphenous vein ablation options

Data in the pipeline for “toolbox” of saphenous vein ablation options

Long-awaited US FDA update on paclitaxel-coated devices - Peter Schneider

Long-awaited US FDA update on paclitaxel-coated devices - Peter Schneider

The Arnsberg ClotTriever study reinforces CLOUT registry outcomes

The Arnsberg ClotTriever study reinforces CLOUT registry outcomes

Deep vein arterialisation “a procedure in evolution”

Deep vein arterialisation “a procedure in evolution”

Can sirolimus-coated balloons overcome current treatment challenges for CLTI patients?

Can sirolimus-coated balloons overcome current treatment challenges for CLTI patients?

Study finds Serranator serration balloon safe and effective in pedal arteries

Study finds Serranator serration balloon safe and effective in pedal arteries

Cost effectiveness of urea-based DCB treatment for CLTI patients “extremely important”

Cost effectiveness of urea-based DCB treatment for CLTI patients “extremely important”

BIOPACT RCT suggests Passeo-18 Lux DCB non-inferior to IN.PACT Admiral DCB

BIOPACT RCT suggests Passeo-18 Lux DCB non-inferior to IN.PACT Admiral DCB

First vascular surgery training requirements looks to harmonise European curriculum

First vascular surgery training requirements looks to harmonise European curriculum

IN.PACT Admiral DCB a cost-effective treatment for CLTI new study shows

IN.PACT Admiral DCB a cost-effective treatment for CLTI new study shows

Intravascular ultrasound given “unanimous approval” in consensus doc on peripheral procedural phases

Intravascular ultrasound given “unanimous approval” in consensus doc on peripheral procedural phases

AAA screening: UK programme’s 10-year anniversary prompts renewed push for increasing uptake

AAA screening: UK programme’s 10-year anniversary prompts renewed push for increasing uptake

APERTO DCB a “very promising new technology” for central vein stenosis

APERTO DCB a “very promising new technology” for central vein stenosis

New study comparing DCBs to bare metal stents in femoropopliteal lesions addresses literature gap

New study comparing DCBs to bare metal stents in femoropopliteal lesions addresses literature gap

New data back Indigo aspiration system as “first-line treatment” for acute limb ischaemia

New data back Indigo aspiration system as “first-line treatment” for acute limb ischaemia

Sirolimus-coated balloon a “clear alternative” to paclitaxel-coated balloons

Sirolimus-coated balloon a “clear alternative” to paclitaxel-coated balloons

Demand for “widely applicable” inner branch technology set to increase as evidence builds

Demand for “widely applicable” inner branch technology set to increase as evidence builds

iliCo study investigates the important role of iCover in complex iliac lesions

iliCo study investigates the important role of iCover in complex iliac lesions

Why ClotTriever is a “gamechanger” for the treatment of deep vein thrombosis

Why ClotTriever is a “gamechanger” for the treatment of deep vein thrombosis

Vascular surgery and its place in a “changing training paradigm”

Vascular surgery and its place in a “changing training paradigm”

Vascular community needs a “clear strategy” for treating severely calcified lesions

Vascular community needs a “clear strategy” for treating severely calcified lesions

Key documents, COVID-19 recovery and device capture: New VSGBI president on goals for the year ahead

Key documents, COVID-19 recovery and device capture: New VSGBI president on goals for the year ahead

Face to face workshops “crucial” to teaching trainee physicians at congresses

Face to face workshops “crucial” to teaching trainee physicians at congresses

AI tipped to be a “gamechanger” in aortic procedures

AI tipped to be a “gamechanger” in aortic procedures

Episode 4: Real world data show IN.PACT Admiral DCB is “very efficient” even in complex lesions

Episode 4: Real world data show IN.PACT Admiral DCB is “very efficient” even in complex lesions

New SVS vice president: 'How do vascular surgeons differ? We provide comprehensive vascular care'

New SVS vice president: 'How do vascular surgeons differ? We provide comprehensive vascular care'

How COVID-19 has highlighted the “many benefits” of office based labs

How COVID-19 has highlighted the “many benefits” of office based labs

Lack of access to vascular specialists creates major disparities in amputation rates across the USA

Lack of access to vascular specialists creates major disparities in amputation rates across the USA

Episode 2: Are all peripheral drug-coated balloons created equal?

Episode 2: Are all peripheral drug-coated balloons created equal?

BlueDop Vascular Expert provides actionable information to revolutionise patient triage

BlueDop Vascular Expert provides actionable information to revolutionise patient triage

Go behind the scenes to delve into the birth and evolution of DCBs for peripheral interventions

Go behind the scenes to delve into the birth and evolution of DCBs for peripheral interventions

Study shows those with in-tack restenosis have shorter lesions than those with in-stent restenosis

Study shows those with in-tack restenosis have shorter lesions than those with in-stent restenosis

Lower-dose SurVeil DCB achieves non-inferiority with IN.PACT Admiral balloon

Lower-dose SurVeil DCB achieves non-inferiority with IN.PACT Admiral balloon

IN.PACT Global study shows DCB “safe and effective” in clinically-complex CLI cohort

IN.PACT Global study shows DCB “safe and effective” in clinically-complex CLI cohort

COMPARE trial: low dose DCB is “as safe and efficacious” as high dose DCB for fempop interventions

COMPARE trial: low dose DCB is “as safe and efficacious” as high dose DCB for fempop interventions

COVER finds increasing competition for services to be expected due to reduction in services globally

COVER finds increasing competition for services to be expected due to reduction in services globally

Complex intervention needed to prevent common problem of renal injury during endovascular procedures

Complex intervention needed to prevent common problem of renal injury during endovascular procedures

ILLUMENATE four-year pooled analysis has “brought increased clarity” to the paclitaxel controversy

ILLUMENATE four-year pooled analysis has “brought increased clarity” to the paclitaxel controversy

DISRUPT PAD III results and how they fit into the endovascular war against severe calcification

DISRUPT PAD III results and how they fit into the endovascular war against severe calcification

“Competing safety profiles” of PE devices muddies decision-making

“Competing safety profiles” of PE devices muddies decision-making

REALITY study “sets new benchmark” for assessment of claudicants with severe femoropopliteal disease

REALITY study “sets new benchmark” for assessment of claudicants with severe femoropopliteal disease

International collaboration on rare vascular diseases hindered by “very strict” EU data rules

International collaboration on rare vascular diseases hindered by “very strict” EU data rules

COVID-19: The role of vascular surgeons—A New York centre perspective

COVID-19: The role of vascular surgeons—A New York centre perspective

Real-world data with long-term follow-up confirm no increased mortality signal with PTX-based device

Real-world data with long-term follow-up confirm no increased mortality signal with PTX-based device

Tack Endovascular System® reveals “impressive” six-month results below the knee

Tack Endovascular System® reveals “impressive” six-month results below the knee

XTOSI study interim findings suggest “highly promising” safety and efficacy of sirolimus DCB

XTOSI study interim findings suggest “highly promising” safety and efficacy of sirolimus DCB

LINC 2020: Novel sirolimus-eluting nitinol stent can address “unmet need” of durability in the SFA

LINC 2020: Novel sirolimus-eluting nitinol stent can address “unmet need” of durability in the SFA

Bioresorbable stents offer clinical efficacy without permanent presence in infrapopliteal arteries

Bioresorbable stents offer clinical efficacy without permanent presence in infrapopliteal arteries

LINC 2020: Geographical “inconsistencies” cast doubt on paclitaxel mortality signal

LINC 2020: Geographical “inconsistencies” cast doubt on paclitaxel mortality signal

VEITH 2019: Vessel preparation “is the key to success” when using drug-eluting technology

VEITH 2019: Vessel preparation “is the key to success” when using drug-eluting technology

VEITH 2019: Percutaneous AV fistulas “not actually sacrificing” options, but rather “expanding” them

VEITH 2019: Percutaneous AV fistulas “not actually sacrificing” options, but rather “expanding” them

Real-world evidence shows no increased mortality signal with PTX-coated device use in claudicants

Real-world evidence shows no increased mortality signal with PTX-coated device use in claudicants

VEITH 2019: The future of endovascular aneurysm sealing (EVAS)

VEITH 2019: The future of endovascular aneurysm sealing (EVAS)

Real-time tissue perfusion device can assess re-establishment of blood flow to foot microcirculation

Real-time tissue perfusion device can assess re-establishment of blood flow to foot microcirculation

COMPARE RCT shows similar key outcomes between low-and high-dose drug-coated balloons

COMPARE RCT shows similar key outcomes between low-and high-dose drug-coated balloons

Independent analysis, with oncology input, re-examines DCB data after paclitaxel mortality signal

Independent analysis, with oncology input, re-examines DCB data after paclitaxel mortality signal

Hospitals face “real challenge” of finding sensible solutions to treat CLI “epidemic”

Hospitals face “real challenge” of finding sensible solutions to treat CLI “epidemic”

VEITH 2019: Tackling dehydration has a “tremendous impact” when treating claudication patients

VEITH 2019: Tackling dehydration has a “tremendous impact” when treating claudication patients

VEITH 2019: “It was like the wild west”: Hazim Safi takes a look back at his vascular training years

VEITH 2019: “It was like the wild west”: Hazim Safi takes a look back at his vascular training years

Combination of scaffold and drug in BTK intervention “without question” the right way forward

Combination of scaffold and drug in BTK intervention “without question” the right way forward

IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries

IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries

Medtronic IN.PACT™ AV DCB, now approved for AV fistula maintenance in the US

Medtronic IN.PACT™ AV DCB, now approved for AV fistula maintenance in the US

VEITH 2019: “Light at the end of the tunnel” following paclitaxel collaboration

VEITH 2019: “Light at the end of the tunnel” following paclitaxel collaboration

VEITH 2019: Paclitaxel controversy propels innovation in endovascular BTK treatment

VEITH 2019: Paclitaxel controversy propels innovation in endovascular BTK treatment

Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee angioplasty

Shockwave IVL can aid in eliminating recoil and dissection during below-the-knee angioplasty

TCAR “combines best of both worlds” but carotid endarterectomy “remains the gold standard”

TCAR “combines best of both worlds” but carotid endarterectomy “remains the gold standard”

Michael Conte responds to new meta-analysis of paclitaxel-coated balloons in infrapopliteal arteries

Michael Conte responds to new meta-analysis of paclitaxel-coated balloons in infrapopliteal arteries

Vascular surgeons and cardiologists respond to new meta-analysis of PCBs in infrapopliteal arteries

Vascular surgeons and cardiologists respond to new meta-analysis of PCBs in infrapopliteal arteries

Physicians “must weigh long-term outcomes” against “short-term benefits” for aortic repair devices

Physicians “must weigh long-term outcomes” against “short-term benefits” for aortic repair devices

High-quality evidence from multiple sources “key” to holistic assessment of endograft performance

High-quality evidence from multiple sources “key” to holistic assessment of endograft performance

Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic patients

Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic patients

LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts

LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts

Innovation summit brings different specialties together to “learn more than they would otherwise”

Innovation summit brings different specialties together to “learn more than they would otherwise”

VSASM 2019: SVT president emphasises importance of collaboration with vascular surgeons

VSASM 2019: SVT president emphasises importance of collaboration with vascular surgeons

VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new era in image-guided therapy

VEITH 2019: Fiber Optic RealShape (FORS) technology could spark a new era in image-guided therapy

“Extreme care” needed not to overgeneralise when creating AAA guidelines using RCT data | VSASM 2019

“Extreme care” needed not to overgeneralise when creating AAA guidelines using RCT data | VSASM 2019

EVAR before, and EVAR after: VEITH TV looks back with the pioneers

EVAR before, and EVAR after: VEITH TV looks back with the pioneers

Slow rebalancing, not “seismic overnight change” in practice expected after NICE AAA guidelines

Slow rebalancing, not “seismic overnight change” in practice expected after NICE AAA guidelines

EXTRACT-PE an “important first study” for aspiration thrombectomy in acute PE patients

EXTRACT-PE an “important first study” for aspiration thrombectomy in acute PE patients

New trial planned to rigorously test catheter-directed thrombolysis for submassive PE treatment

New trial planned to rigorously test catheter-directed thrombolysis for submassive PE treatment

More focus needed on best medical therapy and perfusion imaging for CLI procedures

More focus needed on best medical therapy and perfusion imaging for CLI procedures

VIVA 2019: PROMISE I trial shows deep vein arterialisation offers hope to no-option CLI patients

VIVA 2019: PROMISE I trial shows deep vein arterialisation offers hope to no-option CLI patients

CLI: “Know the patient, know the disease and know what you can do to fix it”

CLI: “Know the patient, know the disease and know what you can do to fix it”

Global Vascular Guidelines a ‘huge collaborative achievement’

Global Vascular Guidelines a ‘huge collaborative achievement’

Politicians and physicians “should work together” for solutions to reduce major amputation rates

Politicians and physicians “should work together” for solutions to reduce major amputation rates

GORE®ACTIVE CONTROL System takes TEVAR to the next level with “convincing” results’

GORE®ACTIVE CONTROL System takes TEVAR to the next level with “convincing” results’

ESVS 2019: “Specific need” for improved management in ruptured AAAs in women

ESVS 2019: “Specific need” for improved management in ruptured AAAs in women

ESVS 2019: HT-CLI trial to definitively test if cell technology can salvage limbs in CLI patients

ESVS 2019: HT-CLI trial to definitively test if cell technology can salvage limbs in CLI patients

SVS 2019: Multidisciplinary limb salvage teams produce “excellent results”

SVS 2019: Multidisciplinary limb salvage teams produce “excellent results”

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

CIRSE 2019: OUTBACK™ Elite Re-entry catheter highly effective at saving limbs in extreme CTOs

CIRSE 2019: OUTBACK™ Elite Re-entry catheter highly effective at saving limbs in extreme CTOs

Experts discuss latest results from EFFPAC and TINTIN trials presented at CIRSE 2019

Experts discuss latest results from EFFPAC and TINTIN trials presented at CIRSE 2019

SVS 2019: Elderly patients should not be denied TEVAR based on age alone

SVS 2019: Elderly patients should not be denied TEVAR based on age alone

VascularNews Live Stream

VascularNews Live Stream

SVS 2019: Why the proposed NICE guidelines are “not so nice”

SVS 2019: Why the proposed NICE guidelines are “not so nice”

NICE abdominal aortic guideline takes an “unprecedented” turn

NICE abdominal aortic guideline takes an “unprecedented” turn

Webinar: Safety of paclitaxel devices – what does the evidence say?

Webinar: Safety of paclitaxel devices – what does the evidence say?

Large real-world dataset finds TCAR compares favourably with CEA for carotid artery disease patients

Large real-world dataset finds TCAR compares favourably with CEA for carotid artery disease patients

Overnight you are on the frontline: Easing the transition from medical student to vascular resident

Overnight you are on the frontline: Easing the transition from medical student to vascular resident

Wearables could transform monitoring and outcome assessment for vascular interventions

Wearables could transform monitoring and outcome assessment for vascular interventions

SVS addresses uncomfortable survey on physician burnout and depression head-on and with intention

SVS addresses uncomfortable survey on physician burnout and depression head-on and with intention

SVS VQI data being “fortified” to shed light on long-term paclitaxel device use in the periphery

SVS VQI data being “fortified” to shed light on long-term paclitaxel device use in the periphery

Apps and handy references planned to disseminate Global Vascular CLTI Guidelines

Apps and handy references planned to disseminate Global Vascular CLTI Guidelines

Two-year trial data shows “astonishing results” for luminor DCB

Two-year trial data shows “astonishing results” for luminor DCB

Only Eluvia Uses a Polymer for Controlled, Targeted Delivery of the Lowest Drug Dose

Only Eluvia Uses a Polymer for Controlled, Targeted Delivery of the Lowest Drug Dose

VLF 2019: “We learnt a lot more about paclitaxel”

VLF 2019: “We learnt a lot more about paclitaxel”

Two trials in the wake of the paclitaxel-coated products controversy

Two trials in the wake of the paclitaxel-coated products controversy

Government funding for large randomised trials still needed to examine promise of new therapies

Government funding for large randomised trials still needed to examine promise of new therapies

Multiple RCTs evaluating EVAR enabled pooling of data in quest for high-quality evidence

Multiple RCTs evaluating EVAR enabled pooling of data in quest for high-quality evidence

Sirolimus has “a much wider” safety window and shows fewer local effects than paclitaxel

Sirolimus has “a much wider” safety window and shows fewer local effects than paclitaxel

VLF 2019: White paper and individual patient data analysis are planned next steps

VLF 2019: White paper and individual patient data analysis are planned next steps

60s insight from VLF 2019: Assessing mortality in endovascular trials

60s insight from VLF 2019: Assessing mortality in endovascular trials

30s insight from VLF 2019: JAHA meta-analysis catalysed cross-specialty interest

30s insight from VLF 2019: JAHA meta-analysis catalysed cross-specialty interest

Customising therapy in femoropopliteal revascularisation

Customising therapy in femoropopliteal revascularisation

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

Thrombus dissolution with EKOS™ Acoustic Pulse Thrombolysis™ in everyday clinical practice

Identifying and repairing dissections that matter

Identifying and repairing dissections that matter

Comparing and contrasting surgically-created AVFs with those made by endovascular means

Comparing and contrasting surgically-created AVFs with those made by endovascular means

VIVA 2018 focuses on the critical issues in vascular medicine

VIVA 2018 focuses on the critical issues in vascular medicine

How does the novel Temporary Spur device work to “guarantee” drug delivery to vessel wall?

How does the novel Temporary Spur device work to “guarantee” drug delivery to vessel wall?

ULTRASCORE scoring helps obtain luminal gain at low inflation pressure before Lutonix DCB use

ULTRASCORE scoring helps obtain luminal gain at low inflation pressure before Lutonix DCB use

Patient-level analysis shows no correlation between paclitaxel and mortality—reactions from LINC

Patient-level analysis shows no correlation between paclitaxel and mortality—reactions from LINC

New data release at LINC 2019 reinforces safety profile of low-dose Stellarex DCB

Reimbursement for CAS in the USA could be tied to operator experience and adjudication of cases

Reimbursement for CAS in the USA could be tied to operator experience and adjudication of cases

IN.PACT patient-level meta-analysis shows no correlation between paclitaxel exposure and mortality

IN.PACT patient-level meta-analysis shows no correlation between paclitaxel exposure and mortality

GREAT study to shed light on long-term outcomes of aortic repair

GREAT study to shed light on long-term outcomes of aortic repair

New global vascular guidelines for CLTI patients now open for stakeholder comment

New global vascular guidelines for CLTI patients now open for stakeholder comment

PCSK9 inhibitors, rivaroxaban and a diabetes drug are major milestones in PAD treatment

PCSK9 inhibitors, rivaroxaban and a diabetes drug are major milestones in PAD treatment

Be an early adopter of AI to harness its benefits

Be an early adopter of AI to harness its benefits

Fusion imaging makes visible for the whole team what is in the operator's mind

Fusion imaging makes visible for the whole team what is in the operator's mind

Lutonix BTK IDE: The first randomised Level 1 trial to show positive safety and efficacy

Lutonix BTK IDE: The first randomised Level 1 trial to show positive safety and efficacy

A niche group of patients who do very well with branched aortic endograft repair

A niche group of patients who do very well with branched aortic endograft repair

Lutonix 014 DCB gathers first randomised evidence of positive safety and efficacy below the knee

Lutonix 014 DCB gathers first randomised evidence of positive safety and efficacy below the knee

TOBA II shows repairing dissections after angioplasty “clearly augments” outcomes for PAD patients

TOBA II shows repairing dissections after angioplasty “clearly augments” outcomes for PAD patients

Open vs. endovascular aneurysm repair in the 60-year-old man against proposed NICE guidelines

Open vs. endovascular aneurysm repair in the 60-year-old man against proposed NICE guidelines

Tackling the uncommon, but devastating, complication of infection after EVAR

Tackling the uncommon, but devastating, complication of infection after EVAR

Appropriate patient selection is vital for good long-term outcomes after EVAR

Appropriate patient selection is vital for good long-term outcomes after EVAR

Building a career in vascular surgery

Building a career in vascular surgery

The important phenomenon of air embolization in endovascular aortic arch interventions

The important phenomenon of air embolization in endovascular aortic arch interventions

Consider intravascular lithotripsy when treating calcified femoropopliteal arteries

Consider intravascular lithotripsy when treating calcified femoropopliteal arteries

So, are you using lower leg lead shields when you perform EVAR?

So, are you using lower leg lead shields when you perform EVAR?

A patient’s health is “the most important” determinant of outcome after surgery

A patient’s health is “the most important” determinant of outcome after surgery

Individual evaluation of each patient, and each aorta, is key to durable repair

Individual evaluation of each patient, and each aorta, is key to durable repair

Lutonix Global AV Registry: DCB use prolongs time to reintervention in failing arteriovenous access

Lutonix Global AV Registry: DCB use prolongs time to reintervention in failing arteriovenous access

IMPERIAL trial shows Eluvia outperforms Zilver PTX at one year

IMPERIAL trial shows Eluvia outperforms Zilver PTX at one year

Stroke from Thoracic Endovascular Procedures (STEP)

Stroke from Thoracic Endovascular Procedures (STEP)

EVAR in short neck and complex aortic anatomy: Sean Lyden

EVAR in short neck and complex aortic anatomy: Sean Lyden

Marc Schermerhorn: Mortality analysis of EVAS vs. EVAR

Marc Schermerhorn: Mortality analysis of EVAS vs. EVAR

Colin Bicknell: Tips and techniques for using EndoAnchors in TEVAR

Colin Bicknell: Tips and techniques for using EndoAnchors in TEVAR

Maria Antonella Ruffino: Mesh-covered stents for carotid artery disease

Maria Antonella Ruffino: Mesh-covered stents for carotid artery disease

Andrew Holden: Update on the IN.PACT AV access trial

Andrew Holden: Update on the IN.PACT AV access trial

Panos Kitrou: First interim LUTONIX DCB AV registry data

Panos Kitrou: First interim LUTONIX DCB AV registry data

Merging the portfolios and strengths of Philips and Spectranetics

Merging the portfolios and strengths of Philips and Spectranetics

Four-year mechanochemical ablation data shared at EVF

Four-year mechanochemical ablation data shared at EVF

Kathleen Gibson: VeClose study three-year results

Kathleen Gibson: VeClose study three-year results

Fabrizio Fanelli: IN.PACT Global study

Fabrizio Fanelli: IN.PACT Global study

Vascular News interviews Michael Dake

Vascular News interviews Michael Dake

CX 2017 Klaus Amendt 1

CX 2017 Klaus Amendt 1

Michael Lichtenberg: Crossing difficult lesions with the Wingman CTO catheter

Michael Lichtenberg: Crossing difficult lesions with the Wingman CTO catheter

Intraoperative arterial flow measuring

Intraoperative arterial flow measuring

Santi Trimatchi: The IRAD Registry

Santi Trimatchi: The IRAD Registry

Stefan Müller-Hülsbeck: The current drug-eluting stent landscape

Stefan Müller-Hülsbeck: The current drug-eluting stent landscape

The highlights of the VEITHsymposium 2013

The highlights of the VEITHsymposium 2013

Bioabsorbable stent shows better results than surgery in patients with CFA stenosis and high BMI

Bioabsorbable stent shows better results than surgery in patients with CFA stenosis and high BMI

Durability paired with innovation: Going low profile should not compromise device performance